文献速递甲状腺疾病性腺与生殖内分泌

母体甲状腺功能与妊娠期高血压及子痫前期风险的关联:系统综述与个体参与者数据荟萃分析

Association between maternal thyroid function and risk of gestational hypertension and pre-eclampsia: a systematic review and individual-participant data meta-analysis.
PubMed 文献 · Lancet Diabetes Endocrinol · 2022-03-04

该系统综述与个体参与者数据荟萃分析检索了MEDLINE、Embase、Scopus和Cochrane系统综述数据库(自建库至2019年12月27日),纳入19个前瞻性队列、46 528名孕妇。与甲状腺功能正常相比,亚临床甲状腺功能减退症与子痫前期风险升高相关(2.1% vs 3.6%;OR 1.53 [95% CI 1.09-2.15]);促甲状腺激素与子痫前期呈U型关联(p=0.0001)。

要点

  • 亚临床甲状腺功能减退症与子痫前期风险升高相关(OR 1.53 [95% CI 1.09-2.15])。
  • 亚临床甲状腺功能亢进症、孤立性低甲状腺素血症或TPO抗体阳性与妊娠期高血压或子痫前期无显著关联。
  • 促甲状腺激素与子痫前期呈U型关联(p=0.0001),游离甲状腺素浓度与结局无关联。

核心结论

  • 与甲状腺功能正常相比,妊娠期亚临床甲状腺功能减退症与子痫前期风险升高相关。
  • 促甲状腺激素与子痫前期呈U型关联。
  • 这些结果量化了甲状腺功能检查异常孕妇发生妊娠期高血压或子痫前期的风险,为妊娠期甲状腺功能异常不良母胎结局风险证据增添了内容。
  • 这些发现对定义妊娠期左甲状腺素治疗妇女的最佳治疗目标具有潜在意义,需在未来的干预性研究中评估。

研究设计与样本

  • 系统综述与个体参与者数据荟萃分析,检索MEDLINE(Ovid)、Embase、Scopus和Cochrane系统综述数据库自建库至2019年12月27日的前瞻性队列研究。
  • 纳入标准为报告母体促甲状腺激素、游离甲状腺素、甲状腺过氧化物酶抗体浓度(单独或联合)以及妊娠期高血压和/或子痫前期数据的研究。
  • 排除孕前已有甲状腺疾病、多胎妊娠或正在服用影响甲状腺功能药物的参与者。
  • 共识别1539项已发表研究,33个队列符合纳入标准,19个队列作者同意参与后被纳入。
  • 研究人群包括46 528名孕妇,其中39 826名(85.6%)有足够数据(促甲状腺激素和游离甲状腺素浓度及甲状腺过氧化物酶抗体状态)可进行甲状腺功能状态分类。

主要发现

  • 39 826名可分类孕妇中,1275名(3.2%)为亚临床甲状腺功能减退症,933名(2.3%)为孤立性低甲状腺素血症,619名(1.6%)为亚临床甲状腺功能亢进症,337名(0.8%)为显性甲状腺功能亢进症。
  • 与甲状腺功能正常相比,亚临床甲状腺功能减退症与子痫前期风险升高相关(2.1% vs 3.6%;OR 1.53 [95% CI 1.09-2.15])。
  • 亚临床甲状腺功能亢进症、孤立性低甲状腺素血症或甲状腺过氧化物酶抗体阳性与妊娠期高血压或子痫前期无显著关联。
  • 连续分析中,较高和较低的促甲状腺激素浓度均与子痫前期风险升高相关(p=0.0001)。
  • 游离甲状腺素浓度与所测结局无关联。

关键数值与推荐

  • 亚临床甲状腺功能减退症与子痫前期:2.1% vs 3.6%;OR 1.53(95% CI 1.09-2.15)。
  • 促甲状腺激素与子痫前期呈U型关联(p=0.0001)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Adequate maternal thyroid function is important for an uncomplicated pregnancy. Although multiple observational studies have evaluated the association between thyroid dysfunction and hypertensive disorders of pregnancy, the methods and definitions of abnormalities in thyroid function tests were heterogeneous, and the results were conflicting. We aimed to examine the association between abnormalities in thyroid function tests and risk of gestational hypertension and pre-eclampsia. METHODS: In this systematic review and meta-analysis of individual-participant data, we searched MEDLINE (Ovid), Embase, Scopus, and the Cochrane Database of Systematic Reviews from date of inception to Dec 27, 2019, for prospective cohort studies with data on maternal concentrations of thyroid-stimulating hormone (TSH), free thyroxine (FT4), thyroid peroxidase (TPO) antibodies, individually or in combination, as well as on gestational hypertension, pre-eclampsia, or both. We issued open invitations to study authors to participate in the Consortium on Thyroid and Pregnancy and to share the individual-participant data. We excluded participants who had pre-existing thyroid disease or multifetal pregnancy, or were taking medications that affect thyroid function. The primary outcomes were documented gestational hypertension and pre-eclampsia. Individual-participant data were analysed using logistic mixed-effects regression models adjusting for maternal age, BMI, smoking, parity, ethnicity, and gestational age at blood sampling. The study protocol was registered with PROSPERO, CRD42019128585. FINDINGS: We identified 1539 published studies, of which 33 cohorts met the inclusion criteria and 19 cohorts were included after the authors agreed to participate. Our study population comprised 46 528 pregnant women, of whom 39 826 (85·6%) women had sufficient data (TSH and FT4 concentrations and TPO antibody status) to be classified according to their thyroid function status. Of these women, 1275 (3·2%) had subclinical hypothyroidism, 933 (2·3%) had isolated hypothyroxinaemia, 619 (1·6%) had subclinical hyperthyroidism, and 337 (0·8%) had overt hyperthyroidism. Compared with euthyroidism, subclinical hypothyroidism was associated with a higher risk of pre-eclampsia (2·1% vs 3·6%; OR 1·53 [95% CI 1·09-2·15]). Subclinical hyperthyroidism, isolated hypothyroxinaemia, or TPO antibody positivity were not associated with gestational hypertension or pre-eclampsia. In continuous analyses, both a higher and a lower TSH concentration were associated with a higher risk of pre-eclampsia (p=0·0001). FT4 concentrations were not associated with the outcomes measured. INTERPRETATION: Compared with euthyroidism, subclinical hypothyroidism during pregnancy was associated with a higher risk of pre-eclampsia. There was a U-shaped association of TSH with pre-eclampsia. These results quantify the risks of gestational hypertension or pre-eclampsia in women with thyroid function test abnormalities, adding to the total body of evidence on the risk of adverse maternal and fetal outcomes of thyroid dysfunction during pregnancy. These findings have potential implications for defining the optimal treatment target in women treated with levothyroxine during pregnancy, which needs to be assessed in future interventional studies. FUNDING: Arkansas Biosciences Institute and Netherlands Organization for Scientific Research.

来源:Lancet Diabetes Endocrinol,查看原文。版权归原作者所有。

引用

  1. Toloza FJK, Derakhshan A, Männistö T, et al. Association between maternal thyroid function and risk of gestational hypertension and pre-eclampsia: a systematic review and individual-participant data meta-analysis. Lancet Diabetes Endocrinol. 2022. PMID: 35255260. doi:10.1016/S2213-8587(22)00007-9

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。